Century Therapeutics, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:IPSC) | MetaTrader

展开完整图表完整图表

新闻

Leerink reiterates Market Perform on Century Therapeutics stock

TD Cowen首次覆盖Century Therapeutics股票,评级为买入

TD Cowen initiates Century Therapeutics stock rating at Buy

Clear Street重申Century Therapeutics股票买入评级，目标价6.60美元

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

Clear Street下调世纪治疗(Century Therapeutics)股价目标至6.60美元

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain